You are here
Dr. Susan Love Research Foundation
Tamoxifen has been used for so long to treat breast cancer that most of us assumed we knew everything that we needed to know about it including how long women should take it. But yesterday at the San Antonio Breast Cancer Symposium we all learned something new when researchers presented results from the ATLAS trial (Adjuvant Tamoxifen: Longer Against Shorter).
Lots of medical meetings are held at this time of year, which means lots of media coverage of new breast cancer research. Whenever you hear about a new study, keep in mind that any results that are presented but not published have not passed the critical peer review process and are considered preliminary.